BBK Capital Partners »

Aeon Biopharma shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 20k 1.10

More positions owned by BBK Capital Partners

Apple (AAPL)
Procter & Gamble Company (PG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Etf Opportunities Trust Formidable Fortr (KONG)
Meta Platforms Cl A (META)
Etf Opportunities Trust Formidable Etf (FORH)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alibaba Group Hldg Sponsored Ads (BABA)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for BBK Capital Partners

Top funds holding Aeon Biopharma

Dauntless Investment Group
Vanguard Group
Geode Capital Management
XTX Topco
Blue Owl Capital Holdings
BBK Capital Partners
Laird Norton Tyee Trust
Two Sigma Securities
Citadel Advisors
UBS Group
BlackRock
Wolff Wiese Magana
DuPont Capital Management Corporation
SBI Securities
Steward Partners Investment Advisory

View all funds holding Aeon Biopharma